Management options for infantile subglottic hemangioma.
Gregg
C M
CM
Department of Otolaryngology-Head and Neck Surgery, University of Michigan Medical Center, Ann Arbor, USA.
Wiatrak
B J
BJ
Koopmann
C F
CF
D000402:Airway Obstruction / Q000601:surgery; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005931:Glottis / Q000473:pathology; D006391:Hemangioma / Q000151:congenital / Q000628:therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015552:Injections, Intralesional; D007442:Intubation, Intratracheal; D007822:Laryngeal Neoplasms / Q000151:congenital / Q000628:therapy*; D053685:Laser Therapy; D008297:Male; D009365:Neoplasm Regression, Spontaneous; D010347:Patient Care Planning; D014139:Tracheostomy; D014140:Tracheotomy; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D014222:Triamcinolone Acetonide